Stephen Haworth

Company: XORTX Therapeutics Inc.

Job title: CMO

Seminars:

Highlighting a Two-Step Clinical Development Program Using Total Kidney Volume as a Surrogate in ADPKD 9:30 am

Reformulating a xanthine oxidase inhibitor for use in PKD treatment  Moving towards accelerated approval: smaller registration trial using total kidney volume as a surrogate  Putting in place a more extensive study for full approval Read more

day: Conference Day One